Pharming Group N.V.: Pharming Group reports second quarter and first half 2023 financial results : vimarsana.com

Pharming Group N.V.: Pharming Group reports second quarter and first half 2023 financial results

Pharming Group N.V.: Pharming Group reports second quarter and first half 2023 financial results

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Canada , United Kingdom , Amsterdam , Noord Holland , Netherlands , Israel , United States , London , City Of , Japan , Australia , America , Australian , Dutch , Canadian , Japanese , Israeli , Paul Sekhri , Barbara Yanni , Deborah Jorn , Michael Levitan , Leonard Kruimer , Foster Mitchell Alex Shaw , Steven Baert , Alexander Breidenbach , Heather Robertson , Richard Peters , Mark Pykett , Drug Administration , Exchange Commission , Prnewswire Pharming Groupnv , International Accounting Standard , Regulatory Agency , Pharming Group , Israeli Ministry Of Health , Novartis , Committee For Human Medicinal Products , Company Euronext Amsterdam , Therapeutic Goods Administration , Vp Investor Relations Corporate Communications , International Accounting Standards Board , Linkedin , Access Program , Expert Group , Drug Submission To Health Canada , European Medicines Agency , Patient Program , Devices Agency , Lifespring Life Sciences Communication , International Financial Reporting Standards , European Commission Decision Reliance Procedure , Nasdaq , Japan Pharmaceuticals , Ministry Of Health , Investor Relations Corporate Communications , Euronext Amsterdam , Executive Officer , Sijmen De Vries , Expanded Access Program , Open Label Extension , Priority Review , Rare Pediatric Disease Priority Review Voucher , Annual Report , Human Medicinal Products , Marketing Authorisation Application , Ad Hoc Expert Group , Scientific Advisory Groups , Orphan Drug Designation , Medical Devices Agency , New Drug Submission , Health Canada , Product Registration Application , Israeli Ministry , Pediatric Investigational Plan , Investigational New Drug , Chief Business , Non Executive Director , Extraordinary General Meeting , Chief Business Officer , Chief Development Officer , Marketing Authorisation , Conference Call Dial In Details , Investor Relations , Corporate Communications , Spring Life Sciences Communication , North America , Middle East , Dutch Financial Supervision Act , Executive Director , Chief Executive , Consolidated Interim Financial Statements , Dutch Civil Code , Pivot Park , Orchard Therapeutics , Executive Committee , Aktien Sie ,